Zapping the brain from outside the skull: a new hope for Drug-Resistant epilepsy?

NCT ID NCT07764718

First seen Aug 14, 2026 ยท Last updated Aug 14, 2026

Summary

This trial tests whether a non-invasive technique called temporal interference (TI) stimulation can reduce abnormal electrical activity in the brains of adults with drug-resistant focal epilepsy. Participants, who are already undergoing brain monitoring with implanted electrodes for clinical care, will receive TI stimulation through scalp electrodes during wakefulness and, when possible, natural sleep. The study will measure changes in epilepsy-related brain signals and sleep rhythms, and compare TI with direct electrical stimulation delivered through the implanted electrodes.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Non-invasive temporal interference electrical stimulation delivered through scalp electrodes, compared with direct electrical stimulation via implanted electrodes.
What this could lead to
If successful, this could point toward a non-invasive way to calm seizure-related brain activity and improve sleep rhythms in people with epilepsy, potentially offering an alternative to more invasive treatments.
What could go wrong
This is an early, small study focused on brain activity markers, not seizure reduction. The effects may not translate into real-world seizure control, and the stimulation may not be effective or comfortable for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT FOCAL EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.